Day: March 20, 2024

Posted on

Zoom announces communications compliance solution, Zoom Compliance Manager

Zoom Compliance Manager provides a single integrated platform for risk and compliance management, data governance, and information protection across the Zoom platform, powered by Theta Lake

SAN JOSE, Calif., March 20, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) today announced the launch of Zoom Compliance Manager, an all-in-one offering that provides archiving, eDiscovery, legal hold, and information protection capabilities to help organizations fulfill regulatory requirements and mitigate organizational communications compliance risks across the Zoom platform.

“Zoom currently provides compliance and information protection for enterprise customers within regulated industries like financial services, healthcare, and the public sector through integrations with key communications compliance providers,” said Ritu Mukherjee, head of Product Business Acceleration and Readiness at Zoom. “With Zoom Compliance Manager, we are making it easy for our customers to have an end-to-end experience — seamless buying, easy setup, centralized management, and simplified support — with a comprehensive solution that addresses their communications compliance needs across the Zoom platform.”

Addressing Customer Needs
Organizations today face increasingly stringent regulatory requirements and communications compliance risks both internally and externally, which can result in hefty fines, legal liabilities, and reputation damage. This underscores the critical need for robust compliance solutions that help organizations navigate these challenges. Zoom Compliance Manager powered by Theta Lake allows you to confidently use Zoom while maintaining regulatory requirements.

Key features of Zoom Compliance Manager include:

  • Archiving and Content Capture: Maximize your Zoom usage and meet regulatory and long-term record retention requirements with automatic capture for meetings data, AI summaries, phone recordings, team chat, whiteboard content, and more.
  • eDiscovery: Discover insights across the Zoom platform via a user-friendly interface, facilitating easy access to communication archives and offering the ability to analyze, evaluate, and effortlessly export content.
  • Legal Hold: Capture and hold communications of specific individuals and manage cases through custom workflow, case management, and data export requests when legally mandated.

A future version of Zoom Compliance Manager will include:

  • Risk Detection: Monitor and detect spoken, written, or shared content at scale across supported products using intelligent detection which identify regulatory, privacy, conduct, and security risks in what was said, shown, and shared to mitigate risks.
  • Data Loss Prevention: Identify and mitigate potential risks in your communication workflows using both custom and pre-defined policies through monitoring and thorough analysis.

Zoom Compliance Manager provides compliance capabilities across the Zoom platform, including AI Companion, Meetings, Team Chat, Phone, Whiteboard, Rooms, Webinars, Events, and Contact Center. Zoom Compliance Manager is available as an add-on to Zoom customers with a paid plan.

Support for other Zoom products, including Workvivo, Zoom Revenue Accelerator, Mail, Calendar, and others, will be coming later this year.

Leveraging Theta Lake as a Leader in Compliance and Security

Zoom Compliance Manager integrates the proven compliance solution from Theta Lake, a leader in digital communications governance providing modern communication compliance and security solutions. Through Zoom-specific enhancements, customers will have the compliance benefits of Theta Lake with a frictionless Zoom experience via the administrator console.

“Our expanded compliance and security capabilities for Zoom, along with the ability to use Theta Lake technology, represents a significant milestone in our partnership,” said Anthony Cresci, SVP of GTM and Partnerships at Theta Lake. “With this new offering we are able to provide organizations with seamless and efficient access to communication and collaboration capabilities that have compliance record keeping, archiving, search, supervision, and data protection built in. I am incredibly proud of expanding the value and innovation that our partnership has delivered to our joint customers.”

Experience the Solution

Attendees of Enterprise Connect, taking place March 25-28, are encouraged to visit the Zoom booth (#407) and the Theta Lake booth (#2026). To experience a live demo of Zoom Compliance Manager, visit the Zoom booth on March 26 at 5:30 p.m. EST.

For more information, please visit the Zoom Compliance Manager landing page at https://click.zoom.us/compliance-manager

About Zoom
Zoom is an all-in-one intelligent collaboration platform that makes connecting easier, more immersive, and more dynamic for businesses and individuals. Zoom technology puts people at the center, enabling meaningful connections, facilitating modern collaboration, and driving human innovation through solutions like team chat, phone, meetings, omnichannel cloud contact center, smart recordings, whiteboard, and more, in one offering. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more info at zoom.com.

Zoom Public Relations
Travis Isaman
press@zoom.us

GlobeNewswire Distribution ID 9066412

Posted on

Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints

Reports an Apnea-Hypopnea Index (AHI) responder rate of 63.5% on an intent to treat (ITT) basis (p=0.002)
Reports an Oxygen Desaturation Index (ODI) responder rate of 71.3% on an intent to treat (ITT) basis (p<0.001)
Median 12-month AHI reduction of 70.8%

Mont-Saint-Guibert, Belgium – March 19, 2024, 9:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the DREAM U.S. pivotal study achieved a statistically significant reduction in the co-primary endpoints of 12-month AHI responder rate, per the Sher criteria, and ODI responder rate, both on an ITT basis.

The DREAM study is a pivotal trial, being conducted under an investigational device exemption (IDE) and is designed to support the marketing authorization of the Genio® hypoglossal nerve stimulation system (HGNS) in the United States. This multicenter, prospective, open-label, interventional study enrolled 115 patients and has co-primary efficacy endpoints of the Apnea-Hypopnea Index (AHI) responder rate, per the Sher criteria, and the Oxygen Desaturation Index (ODI) responder rate, both measured at 12 months*. Subjects also were required to sleep supine for at least 60 minutes at their 12-month polysomnography test (PSG). More information regarding the study can be found in section 1.5.4 of the Company’s annual report regarding financial year 2022, which can be found on the Company’s website using the following link: Nyxoah Annual Report 2022 EN.pdf.

Study participants entered the DREAM study with a mean AHI of 28.0, mean ODI of 27.0 and mean body mass index of 28.5. At 12 months, 73 subjects were determined to be AHI responders, per the Sher criteria, resulting in an ITT AHI responder rate of 63.5% (p=0.002), and 82 subjects were determined to be ODI responders, resulting in an ODI responder rate of 71.3% (p<0.001). Subjects demonstrated a median 12-month AHI reduction of 70.8%, with similar AHI improvements in supine and non-supine sleeping positions. The safety results for the investigational treatment were favorable, with 11 serious adverse events, or SAEs, in ten subjects resulting in an SAE rate of 8.7%. Out of the 11 SAEs, three were device related and there were three explants.

“DREAM is a pivotal, multicenter, international study of Genio, a next generation HGNS technology offering patients bi-lateral stimulation with a non-implanted battery solution powered and controlled by a wearable. With the DREAM data, Genio has demonstrated positive efficacy results that OSA patients, having failed traditional medical therapies, have come to expect. Notably, Genio’s unique bilateral stimulation provides the potential for improved outcomes for a wider spectrum of OSA patients. I am excited that Nyxoah and Genio are working towards expanding options and advancing HGNS therapy for OSA, and I look forward to offering it to my patients upon FDA approval,” commented B Tucker Woodson, MD, Chief, Professor – Medical College of Wisconsin and Principal Investigator of the DREAM study.”

“I am excited to report the positive DREAM results, as they pave the way for Genio to shift the OSA treatment paradigm in the U.S. With Genio’s patient centric design, strong clinical data and commercial learnings from Europe, we are confident Nyxoah can become a leading OSA company.” commented Olivier Taelman, Nyxoah’s Chief Executive Officer. “We are finalizing the fourth and final module submission in the PMA application and I look forward to launching Genio in the U.S, pending FDA approval.”

Conference call and webcast presentation

Company management will host a conference call to discuss the DREAM results today beginning at 9:30pm CET / 4:30pm ET. A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: DREAM Results Webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: DREAM Results Call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please see the Company’s annual report for the financial year 2023 which will be filed on March 20, 2024 and visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-looking statements

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; reporting data from Nyxoah’s DREAM U.S. pivotal trial; filing for FDA approval; and entrance to the U.S. market. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2022, filed with the Securities and Exchange Commission (“SEC”) on March 22, 2023, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contact:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

GlobeNewswire Distribution ID 1000930141

Posted on

ITALIAN AMBASSADOR PAYS GEAGEA FAREWELL VISIT

Lebanese Forces" party leader, Samir Geagea, on Wednesday welcomed at his Maarab residence Italian Ambassador to Lebanon, Nicoletta Bombardiere, who paid him a farewell visit upon winding her diplomatic mission in Lebanon. During the meeting, both sides discussed the importance of preserving the historical ties between Lebanon and Italy, as well as delving into local, regional, and international political situations. Source: National News Agency - Lebanon

Posted on

MIKATI STRESSES DIALOGUE, MUTUAL RESPECT AT FRANCOPHONE CELEBRATION

Caretaker Prime Minister, Najib Mikati, on Wednesday emphasized that Lebanon's only choice for progress is through constructive dialogue, mutual respect, and embracing tolerance, particularly within diversity. He highlighted the importance of humanitarian values, such as those embodied by the Francophonie, in navigating ethical and moral challenges. Mikati's remarks came during a celebration marking the International Day of the Francophonie held at the Grand Serail. "For us Lebanese, celebrating the Francophonie goes beyond our linguistic affiliation because, as former President Senghor said, 'Francophonie is culture. It is a way of thinking and behaving. It is using the French language as a tool for coexistence, beyond our national or regional languages, to enhance our cultural and technical cooperation, despite the differences in our civilizations.' These humanitarian principles of participation, solidarity, brotherhood, and justice are precisely what distinguish the cradle of French speakers, which we pr oudly share without denying anything from our Lebanese identity,' Mikati said. "Lebanon, unique in its pluralism, which is a mosaic of political ideologies and religious sects, has no choice but to follow the path of constructive dialogue, mutual respect, and tolerance, which represents harmony within diversity. These principles have always guided my political action, and I am more attached to them at this moment of the multidimensional crisis that we must face with solidarity, cooperation, and calm. Unfortunately, in addition to this crisis, we are still victims of the Israeli aggression, which continues to violate the international law by targeting civilians and infrastructure, and persists in the deliberate destruction of natural and agricultural ecosystems,' Mikati added. "We, the Lebanese, are determined to live and never surrender. I would like to take this opportunity of our meeting to extend greetings to the first Lebanese French-speaking newspaper, 'L'Orient-Le Jour,' which launched its centenary c elebrations in February. This newspaper has always defended, despite the winds and tides, a free, pluralistic, and sovereign Lebanon, always standing as a fierce defender of public freedoms and freedom of the press. To its entire family, and to all free and responsible media, warm congratulations,' Mikati concluded. In his speech, Levon Amirjanyan, Representative of the Francophonie Organization for the Middle East, highlighted Lebanon's central role in promoting the French language and Francophonie values in the region, noting Lebanon's contributions to building institutional Francophonie and showcasing linguistic diversity through its cultural diversity. The Tunisian Ambassador to Lebanon and President of the Francophone Ambassadors Group in Lebanon, Burawi Al-Imam , expressed determination to work together as French-speaking ambassadors in coordination with our Lebanese friends for a stable, prosperous, and leading Lebanon in the region, hoping that Lebanon would quickly regain its role as a model countr y for coexistence. Source: National News Agency - Lebanon

Posted on

LEBANESE FOREIGN MINISTER HONORS BEAUTY QUEEN YASMINA ZAYTOUN

In a special ceremony, Caretaker Foreign Minister, Abdallah Bou Habib, and Caretaker Tourism Minister, Walid Nassar, welcomed beauty queen Yasmina Zaytoun, who recently won the titles of Miss Asia and Oceania and reaped the first runner-up title in the Miss World beauty pageant. The event was attended by the Chairman of LBC Television, Sheikh Pierre Daher, the Foreign Ministry's Secretary-General, Hani Al-Chamaa, and senior diplomats from the ministry. Minister Bou Habib praised Zaytoun, stating that she was a diplomatic standout in her defense of Lebanon during her participation in the Miss World competition. 'Since we have a just cause that we strive for and address, we say to her, 'you are our ambassador to the world, and we are proud of you.' Bou Habib then granted Zaytoun a diplomatic passport issued by the Ministry of Foreign Affairs to facilitate her work and travels abroad. He also invited her to participate in a diplomatic training course. Tourism Minister Walid Nassar, in turn, noted that "Yasmin a has imposed new standards on the organizers and judges of the Miss World pageant through her distinctive culture, proving that beauty queens are not only judged by their appearance but also by their culture." For her part, Zaytoun thanked Minister Bou Habib for his initiative, expressing her pride in being able to "convey Lebanon's voice to the world and show its beautiful image," also thanking the Ministry of Tourism for its support. Source: National News Agency - Lebanon